![Update on phase 3 study of DTX401.](https://agsd.org.uk/wp-content/uploads/2019/06/ultragenyx-gene-background.jpg)
![Update on phase 3 study of DTX401.](https://agsd.org.uk/wp-content/uploads/2019/06/ultragenyx-gene-background.jpg)
![Update on phase 3 study of DTX401.](https://agsd.org.uk/wp-content/uploads/2019/06/ultragenyx-gene-background.jpg)
Update on the DTX401 programme for GSD1a.
Ultragenyx have provided the following community update on the development of DTX401, their investigational gene therapy for the potential treatment of GSDIa. GSDIa Community...![Liberating Research GSD1a Study.](https://agsd.org.uk/wp-content/uploads/2022/02/research.png)
Liberating Research GSD1a Study.
GSD1a Patient Research Please find below a link to an invitation for UK families affected by GSD1a to take part research by Liberating Research to improve understanding of the impact of the condition. Who can participate?People living with GSD1a and their partners /...![New and Improved CureGSD1b Website.](https://agsd.org.uk/wp-content/uploads/2022/06/Website-update.png)
New and Improved CureGSD1b Website.
The updated CureGSD1b website is now live.
![GSD & ME website is updated.](https://agsd.org.uk/wp-content/uploads/2022/06/New-website.png)
GSD & ME website is updated.
The updated GSD & Me website is now live.
![Moderna mRNA trial infusion for GSD1a.](https://agsd.org.uk/wp-content/uploads/2020/09/shutterstock_727620667-1.jpg)
Moderna mRNA trial infusion for GSD1a.
First patient receives Moderna mRNA trial infusion for GSD1a.